Jiro Yasu and Patrick Rial of Varecs Partners presented their investment thesis on Techno Medica (Japan: 6678) at Asian Investing Summit 2023.

Thesis summary:

Techno Medica is the dominant provider of blood testing preparation machines in Japan. The company is a fabless producer and generates profit mainly from consumables such as labels and printer ink.

Varecs Partners is proposing that the company raise its dividend payout ratio to 100%, reflecting the lack of capex needs and the large cash balance.

The shares recently traded at an EV/EBIT multiple of 3.2x. Jiro and Patrick believe the share price could double if the dividend policy is changed. A similar proposal garnered significant support at last year’s annual meeting. With support from a few other like-minded shareholders, Jiro and Patrick believe success is near.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Jiro Yasu has two decades of investment experience in the Japanese equity markets including at Varecs Partners, First Eagle Investment Management and Daiwa Securities America. As the Representative Director of Varecs Partners, Jiro spearheads the investment firm’s efforts to identify mid-sized listed Japanese companies where corporate value can be realized for all stakeholders by working together with management. Jiro holds a BA in economics with a specialty in econometrics from Keio University.

Patrick Rial joined VARECS Partners in 2015 as Senior Analyst. He joined from J.P. Morgan Securities Japan where he worked in equity strategy and small cap research. Prior to J.P. Morgan, he was a product manager at Morgan Stanley MUFG Securities. Mr. Rial began his career as a financial journalist covering Japanese equity markets. He has been a CFA charterholder since 2011. He holds a BA in economics and history from Georgetown University.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.